High FSCN1 expression was associated with a relatively short overall survival (OS) in patients with LUAD (P = 0.0016) but not in patients with LUSC (P = 0.48), suggesting that the function of FSCN1 may vary in different lung cancer tissues. This evidence concerns the gene FSCN1 and lung carcinoma.